Covered recipient · General Payments record
CHRISHAWNA D SCHIEBER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$610.56
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $267.23 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $56.42 | 3 |
| Exact Sciences Corporation | $44.30 | 3 |
| Amgen Inc. | $33.98 | 2 |
| ABBVIE INC. | $33.86 | 2 |
| Acerta Pharma LLC | $22.49 | 1 |
| DEXCOM, INC. | $19.97 | 1 |
| Lilly USA, LLC | $19.80 | 1 |
| PFIZER INC. | $18.51 | 1 |
| Abbott Laboratories | $17.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.90 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124931328 | CMS |
| ABBVIE INC. | $16.45 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108154205 | CMS |
| ABBVIE INC. | $17.41 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108154207 | CMS |
| Amgen Inc. | $16.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116094225 | CMS |
| Amgen Inc. | $16.99 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116094231 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.49 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105481861 | CMS |
| Dexcom, Inc. | $19.97 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153354398 | CMS |
| Exact Sciences Corporation | $14.93 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114442193 | CMS |
| Exact Sciences Corporation | $14.34 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114442198 | CMS |
| Exact Sciences Corporation | $15.03 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114442202 | CMS |
| Lilly USA, LLC | $19.80 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135624833 | CMS |
| Novo Nordisk Inc | $19.74 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100488979 | CMS |
| Novo Nordisk Inc | $18.49 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100519933 | CMS |
| Novo Nordisk Inc | $18.19 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100580264 | CMS |
| PFIZER INC. | $18.51 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131611312 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.